hackettg

/hackettg

About hackettg

This author has not yet filled in any details.
So far hackettg has created 109 blog entries.

Brand name prescribing status for Tacrolimus products updated on dm+d

Following representation from PSNC, the NHS Business Services Authority (NHSBSA) has added the ‘Caution – AMP level prescribing advised’ marker to oral Tacrolimus products on the Dictionary of medicines and devices (dm+d). This is in line with the MHRA guidance that oral Tacrolimus products should be prescribed and dispensed by brand name only, to minimise [...]

The post Brand name prescribing status for Tacrolimus products updated on dm+d appeared first on PSNC Website.

By |March 23rd, 2023|Lexpos News|Comments Off on Brand name prescribing status for Tacrolimus products updated on dm+d

MHRA Class 2 Medicines Recall: GONAPEPTYL Depot 3.75mg powder and solvent for suspension for injection (Ferring Pharmaceuticals Limited)

Drug alert number: EL(23)A/12 Date issued: 23 March 2023 The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a class 2 medicines recall for: GONAPEPTYL Depot 3.75mg powder and solvent for suspension for injection (Ferring Pharmaceuticals Limited) Batch number Expiry date Pack size First distributed T16656K Mar 2024 1 19 May 2022 U11271E Jun [...]

The post MHRA Class 2 Medicines Recall: GONAPEPTYL Depot 3.75mg powder and solvent for suspension for injection (Ferring Pharmaceuticals Limited) appeared first on PSNC Website.

By |March 23rd, 2023|Lexpos News|Comments Off on MHRA Class 2 Medicines Recall: GONAPEPTYL Depot 3.75mg powder and solvent for suspension for injection (Ferring Pharmaceuticals Limited)

MHRA Class 2 Medicines Recall: Pholcodine-containing products (Various Marketing Authorisation Holders)

Drug alert number: EL (23)A/09 Date issued: 14 March 2023 The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a class 2 medicines recall for: Pholcodine-containing products (Various Marketing Authorisation Holders) Following the conclusion of a review of post-marketing safety data by the MHRA, all pholcodine-containing medicines are being recalled and withdrawn from the [...]

The post MHRA Class 2 Medicines Recall: Pholcodine-containing products (Various Marketing Authorisation Holders) appeared first on PSNC Website.

By |March 14th, 2023|Lexpos News|Comments Off on MHRA Class 2 Medicines Recall: Pholcodine-containing products (Various Marketing Authorisation Holders)

Drug Tariff Watch – March 2023

The Drug Tariff Preface published monthly lists additions, deletions and other changes to products listed in the Drug Tariff. Below is a summary of the changes coming into effect from 1 March 2023. Key g Special container – This product is a special container and should be dispensed in its complete original pack size. n Item [...]

The post Drug Tariff Watch – March 2023 appeared first on PSNC Website.

By |February 27th, 2023|Lexpos News|Comments Off on Drug Tariff Watch – March 2023

DHSC announces rollout of HRT prescription prepayment certificate

The Department of Health and Social Care (DHSC) has today (21st February 2023) announced that women in England will be able to access cheaper Hormone Replacement Therapy (HRT) for menopause through a new Hormone Replacement Therapy prescription prepayment certificate (HRT PPC). From 1st April 2023, women who usually pay for their HRT prescriptions will be able to purchase an [...]

The post DHSC announces rollout of HRT prescription prepayment certificate appeared first on PSNC Website.

By |February 21st, 2023|Lexpos News|Comments Off on DHSC announces rollout of HRT prescription prepayment certificate